Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female patients, ≥ 18 years of age.
Epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Initial surgery, but no chemotherapy or radiotherapy.
Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.
You may not be if
Non-epithelial tumors.
Ovarian tumors with low malignant potential.
Previous systemic anti-cancer therapy for ovarian cancer.
History or evidence of synchronous primary endometrial cancer.
Current or recent daily treatment with aspirin (\> 325mg/day) or with full dose anticoagulant or thrombolytic agents for therapeutic purposes.
Clareo Health | A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
